Article
[Monitoring of low-molecular-weight heparins in pregnant women with inherited thrombophilic disorders].
Akusherstvo i ginekologiia - 1 Jan 2014
Paskaleva I, Karagiozova Zh, Doncheva Ev, Dineva D
Abstract excerpt
Women with thrombophilic disorders have higher risk for venous thromboembolism during pregnancy, as well as risk for vascular damages and complications, including preeclampsia and fetal loss. It is supposed that thrombosis prevention with low-molecular-weight heparins (LMWH) directed against recurrent fetal loss carries antiinflamatory and immunomodulation effects besides its well-known anticoagulation action....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
